<strong>Validation of the feasibility of in-office heart mapping for the diagnosis of cardiac arrhythmia, eliminating the need for surgery or CT scans</strong><strong>Validation of the feasibility of in-office heart mapping for the diagnosis of cardiac arrhythmia, eliminating the need for surgery or CT scans</strong><strong>Validation of the feasibility of in-office heart mapping for the diagnosis of cardiac arrhythmia, eliminating the need for surgery or CT scans</strong><strong>Validation of the feasibility of in-office heart mapping for the diagnosis of cardiac arrhythmia, eliminating the need for surgery or CT scans</strong>
  • Home
  • About us
  • Health Professionals
  • Library
  • News
  • Contact
✕
Corify obtiene financiación de Red.es para el proyecto ai.cor
19 January, 2023
Corify completes the second year of DIDIMO project.
23 March, 2023
14 February, 2023

Validation of the feasibility of in-office heart mapping for the diagnosis of cardiac arrhythmia, eliminating the need for surgery or CT scans

  • A new study from the Universitat Politecnica de Valencia (UPV) and Corify Care demonstrates the effectiveness of Electrocardiographic Imaging (ECGi) in detecting and diagnosing cardiac arrhythmias more accurately and planning treatment more efficiently.

 

  • This breakthrough has the potential to make ECGi a routine tool in clinical practice, bringing the diagnosis and treatment of cardiac arrhythmias closer to patients.

 

For over a hundred years, the main way to diagnose a patient with cardiac arrhythmia has been using a standard electrocardiogram (ECG). This technique allows the detection of these pathologies, but with limited use in identifying the most appropriate treatment for each patient. Recently, a new technology has been developed, Electrocardiographic Imaging (ECGi) which allows the non-invasive mapping of the cardiac activity to without the need of surgery or catheters. Known as the "ECG of the 21st century", it has a significant drawback: it requires the  support  of CT and ECGi scan, which restricts its use to highly complex patients and in leading centres worldwide only.

Now, a study from COR-Instituto ITACA research group from the Universitat Politècnica de València (UPV) and the start-up CorifyCare (https://pubmed.ncbi.nlm.nih.gov/36634462/) has opened a new way to help clinicians and make ECGi a routine clinical application tool.  In their work, published in the Journal of Electrocardiology, they evaluated the possibilities of using ECGi without CT/MRI to detect atrial fibrillation, the most common cardiac arrhythmia. More than 1 million people in Spain suffer from this arrhythmia, and more than 40 million of the world population. This approach enables a quick real-time visual representation of the heart and its electrical activity.

The UPV and Corify Care team analysed the surface signals from 25 patients with atrial fibrillation and compared the effect of using ECGi with imaging techniques and their proposed ECGI with an estimated cardiac geometry based on the anatomical characteristics of the patient's torso.

Their results validated non-imaging ECGi as a robust technique for the non-invasive assessment of atrial fibrillation, demonstrating that it can provide detailed information about the cardiac electrical activity in a much more comprehensive way than conventional ECGs. "This solution will help clinicians to detect and diagnose cardiac arrhythmias more accurately and to provide better and efficient therapeutic strategies for patients," adds Dr Maria Guillem, a researcher in the COR-Instituto ITACA group at the Universitat Politècnica de València.

Rubén Molero, also a researcher with the COR-Instituto ITACA group, highlights that this technique not just reduces patients' exposure to radiation and contrast agents such as CT scans but optimizes cost-efficacy treatments and the procedure time, "facilitating its implementation into clinical practice".

Nowadays, this technology, patented before its publication, is starting the pre-commercial phases by the company Corify Care, granted with the European Innovation Award 2020 by the European Institute of Innovation and Technology.

As Andreu Climent, researcher of the study and CEO of the company, points out, "the ability to obtain maps of the electrical cardiac  activity in a few minutes and safely allows to progress, both in atrial fibrillation and in many other arrhythmias, to increase the accuracy of invasive procedures".

The study has been completed  thanks to different projects funded by the Generalitat Valenciana Conselleria d'Educació, Investigació, Cultura i Esport, the Agencia Estatal de Investigación and the European Institute of Innovation and Technology in Health (EIT-Health).

 

Imgen NotaPrensa UPV (3)

Example of a cardiac map during atrial fibrillation.

Link to "El Español"
Link to "Apunt" Video
Link to "Innospain"
Link to "La Sexta"
Link to "Cadena Ser"
Link to "News Medical"

Related posts

28 March, 2023

NEOTEC project closure at Corify Care


Read more
23 March, 2023

Corify completes the second year of DIDIMO project.


Read more
19 January, 2023

Corify obtiene financiación de Red.es para el proyecto ai.cor


Read more

News

  • NEOTEC project closure at Corify Care
    28 March, 2023
CALL US

+34 910 888 183

OR WRITE

corify@corify.es

Twitter

Retweet on Twitter Corify Care Retweeted
Consortium for Electrocardiographic Imaging @ecgimaging ·
7 Mar

Save the Date! The CEI will be hosting a conference Nov 5th-8th 2023 in Spain. Complete with invited talks and scientific sessions, you won't want to miss this chance to connect ...with fellow ECGI researchers. More details to follow! #epeeps #CardioTwitter
https://www.ecg-imaging.org/announcements/general-announcements

Reply on Twitter 1633127391362187264 Retweet on Twitter 1633127391362187264 11 Like on Twitter 1633127391362187264 10 Twitter 1633127391362187264
2020 Corify. All Rights Reserved. Privacy
      Manage Cookie Consent
      To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
      Functional Always active
      The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
      Preferences
      The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
      Statistics
      The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
      Marketing
      The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
      Manage options Manage services Manage vendors Read more about these purposes
      View preferences
      {title} {title} {title}